Lung Cancer Screening Protocol

Summary

The successful implementation of lung cancer screening across diverse setting requires working with the community and primary care practices. Collaborating across diverse community-based sites will employ local knowledge and culture in the understanding of the health problem and identifying and implementing solutions that are appropriate for all partners (patients, primary care, referral centers). Enhanced, culturally-competent communication with patients at high risk for lung cancer can narrow inequities in screening awareness, referral, and utilization, as well as improve lung cancer outcomes across diverse patients and communities. Promoting partnerships among physicians, staff, and patients; creating routines; and tailoring materials to each clinician's situation have been show to increase the proportion of patients receiving screening.

Conditions

• Lung Cancer Screening

Interventions

OTHER

Toolbox for Lung Cancer Screening

-Toolbox of evidence-based elements that a primary care or referral site could implement to address known barriers to screening and referral, as well as required elements for screening. These elements will be designed to be adaptable to the unique needs and screening processes of the participating practices. * Patient education materials * Primary care practice educational materials * Pack-years/eligibility calculator * Local referral process guide * Smoking cessation materials and support * Shared decision-making guide * LDCT best practice guidelines

Sponsors & Collaborators

• BJC HealthCare, Barnes-Jewish St. Peters Hospital

  collaborator UNKNOWN

• Decatur Memorial Hospital

  collaborator UNKNOWN

• Memorial Health System

  collaborator OTHER

• Sarah Bush Lincoln Health System

  collaborator UNKNOWN

• Southern Illinois Healthcare

  collaborator UNKNOWN

• Cox Health Systems

  collaborator OTHER

• Washington University School of Medicine

  lead OTHER

Principal Investigators

• Aimee S James, Ph.D., MPH · Washington University School of Medicine

• Graham A Colditz, M.D., DrPH · Washington University School of Medicine

Study Design

Allocation

RANDOMIZED

Purpose

SCREENING

Masking

NONE

Model

SEQUENTIAL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2019-04-22

Primary Completion

2021-03-31

Completion

2021-03-31

Countries

• United States

Study Locations